×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
📊
Dashboards
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Dashboards
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
←
Home
/
Wiki
/
Company: AD Tau-Targeting Companies
company
2,530 words
KG: Ad
Contents
AD Tau-Targeting Companies
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Related Hypotheses (11)
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.94
APOE-Dependent Autophagy Restoration
Score: 0.86
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Phase-Separated Organelle Targeting
Score: 0.73
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.73
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.65
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.65
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.62
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
Synaptic Vesicle Tau Capture Inhibition
Score: 0.58
Related Analyses (8)
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Show 3 more
Knowledge Graph (11 edges)
TDP-43
associated_with
Ad
32126838
cannot be concluded ineffective for
Ad
30541566
were significantly higher in
Ad
30541566
was reduced in early stages and highly increased in
Ad
30541566
were increased in
Ad
30541566
was highly increased in
Ad
41660275
significantly elevated in
Ad
41660275
positively correlated in CN but attenuated in
Ad
41660275
elevated in
Ad
39000217
is among the processes affected by
Ad
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)